| 摘要 |
PROBLEM TO BE SOLVED: To provide a marker group for predicting therapeutic effects on hepatitis C, which uses a marker for predicting therapeutic effects on hepatitis C utilizing SNP and comprises a plurality of markers composed of a combination to achieve more precise prediction results regarding therapeutic effects on hepatitis C, probes and primers for the plurality of markers, a testing method and testing kit for predicting therapeutic effects on hepatitis C, which involve the probes and primers.SOLUTION: The marker group for predicting therapeutic effects on hepatitis C includes the first marker, which is an oligonucleotide or polynucleotide including genetic polymorphism rs8099917, and at least one oligonucleotide or polynucleotide selected from genetic polymorphism rs2076954, rs12907066, rs9528038 and rs341554 as another marker. |
